Feng Wang

机构：Shanghai Institute of Pharmaceutical Industry

发表论文 4 篇 · 总被引 116 次 · h-index 4

代表论文

• Thermosensitive Liposomal Codelivery of HSA–Paclitaxel and HSA–Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer (2017 · ACS Applied Materials & Interfaces · 被引 64)
• A Novel Combined Micellar System of Lapatinib and Paclitaxel with Enhanced Antineoplastic Effect Against Human Epidermal Growth Factor Receptor-2 Positive Breast Tumor In Vitro (2014 · Journal of Pharmaceutical Sciences · 被引 30)
• Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles (2014 · Drug Delivery · 被引 18)
• Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration (2014 · Drug Delivery · 被引 4)